Cellular Therapy With Human Autologous Adipose-Derived Adult Stem Cells for Advanced Keratoconus

Abstract

Cellular therapy of the human corneal stroma in vivo with autologous ADASCs appears to be safe. Stem cells survive in vivo with intrastromal new collagen production. Future studies with larger samples are required to confirm these preliminary results.